{{Rsnum
|rsid=2008720
|Gene=PRODH
|Chromosome=22
|position=18936232
|Orientation=minus
|ReferenceAllele=C
|MissenseAllele=A
|GMAF=0.4596
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=PRODH
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 13.8 | 67.7 | 18.5
| HCB | 68.9 | 28.9 | 2.2
| JPT | 50.0 | 43.2 | 6.8
| YRI | 12.7 | 41.3 | 46.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 68.9 | 28.9 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{Venter SNP
|rsid=2008720
|allele=T
|frequency=0.475
|uid=1103691005878
|type=heterozygous_SNP
|hugo=PRODH
|ensembl gene=ENSG00000100033
|ensembl transcript=ENST00000334029
|sift=
|disease=Defects in PRODH are the cause of type I hyperprolinaemia (MIM:239500). It is a disorder characterized by elevated serum proline levels. May be involved in the psychiatric and behavioral phenotypes associated in the 22q11 velocardiofacial syndrome.
}}

{{PMID Auto
|PMID=18408230
|Title=Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}